Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Transplantation and Cellular Therapy|December 22, 2025
Spatial Transcriptomics Analysis of Macrophage-to-Myofibroblast Transition in Bronchiolitis Obliterans Following Hematopoietic Stem Cell TransplantationAkira Yamamoto, Nobuharu Fujii, Keisuke Seike, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 4, 2024
[Relapsed primary central nervous system lymphoma treated with CD19 chimeric antigen receptor T-cell therapy and allogeneic hematopoietic stem cell transplantation]Fuminari Fujii, Toshiki Terao, Hisakazu Nishimori, et al.
British Journal of Haematology|March 23, 2026
Significant clinical impact of immunosuppressive therapy termination after allogeneic haematopoietic stem cell transplantationShigeo Fuji, Akihiro Ohmoto, Yuho Najima, et al.
Transplantation and Cellular Therapy|November 7, 2025
The Limited Impact of Pre-existing Rheumatologic Diseases on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Propensity-Score Matched AnalysisNorina Tanaka, Akihito Shinohara, Shun-Ichi Kimura, et al.
Translational Lung Cancer Research|November 29, 2023
CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancerNaofumi Hara, Eiki Ichihara, Hirohisa Kano, et al.
Leukemia Research|November 12, 2025
Differential impact of graft-versus-host disease on post-transplant outcomes of chronic myelomonocytic leukemia according to transplant proceduresHidehiro Itonaga, Yasushi Miyazaki, Machiko Fujioka, et al.
American Journal of Hematology|March 8, 2025
Adverse Impact of Pre-Transplant Liver Dysfunction in Allogeneic Hematopoietic Cell TransplantationYukiko Misaki, Masaharu Tamaki, Ryu Yanagisawa, et al.
Annals of Hematology|May 8, 2026
WT1 mRNA in peripheral blood enables early prognostic stratification in AML patients receiving venetoclax and azacitidine therapyHiroyuki Sugiura, Noboru Asada, Takeru Asano, et al.
Transplantation and Cellular Therapy|September 5, 2025
Risk Stratification Using DIPSS and Splenomegaly in Myelofibrosis Treated with Pre-Transplant JAK inhibitorsYosuke Okada, Kazuki Sakatoku, Shuichi Shirane, et al.
Blood|December 18, 2024
Oral inflammation and microbiome dysbiosis exacerbate chronic graft-versus-host diseaseYui Kambara, Hideaki Fujiwara, Akira Yamamoto, et al.
Pageof 13